Thursday, April 23, 2020

Temporary FDA Policy for Compounding COVID-19 Drugs Poses Opportunitie...

Temporary FDA Policy for Compounding COVID-19 Drugs Poses Opportunitie...: With COVID-19 cases on the rise in the United States, some hospitals have faced shortages of FDA-approved drug products used to treat the disease. To fill that gap, the FDA recentl...

No comments: